University Hospital Of Jaén Adopts Proscia’s Concentriq Dx To Better Inform Patient Care

Digital pathology platform will improve collaboration across multi-site network and lay the foundation for unlocking new diagnostic insights with AI

Proscia, a leader in digital and computational pathology solutions, and University Hospital of Jaén have partnered to modernize the hospital’s pathology practice. University Hospital of Jaén will leverage Proscia’s Concentriq Dx to optimize routine diagnosis while laying the foundation for implementing artificial intelligence (AI), better informing patient care. This news comes on the heels of Proscia’s formal expansion into Spain to accelerate its international growth.

Recommended AI News: PingCAP’s TiDB Cloud Launches on Google Cloud Marketplace to Reach Developers Globally

Laboratories are rapidly adopting digital pathology, which shifts the 150-year-old standard of care from microscope to whole slide image, to overcome systemic challenges in the traditional laboratory model and capitalize on the growing potential to improve treatment decisions. These digital laboratories are not only driving quality and efficiency gains in routine workflows but also streamlining collaboration among distributed teams and unlocking new diagnostic insights with AI. As University Hospital of Jaén sits at the center of a multi-site network in Andalusia, it recognized that it was in prime position to benefit from digital pathology and selected the scalable, highly-interoperable Concentriq Dx to enable its digital transformation.

CE-marked under IVDR, Concentriq Dx is a singular, secure digital pathology platform that powers routine workflows across the connected enterprise.* Pathologists at University Hospital of Jaén will draw on its intuitive experience for viewing and accessing images to optimize their primary diagnostic workflows. Concentriq Dx also offers live, asynchronous, and remote access to whole slide images, enabling the hospital to streamline collaboration among sites and provide patients with faster access to expertise. The platform’s best-of-breed interoperability will further help pathologists to make more confident diagnoses by unifying siloed data across the network.

Recommended AI News: IXL Learning Acquires Language Learning Software Developer Curiosity Media

“We are excited to have found a platform that will empower us to remain at the forefront of diagnostic medicine,” said Rafael J. Luque Barona, MD Ph.D., Director of the Pathological Anatomy Laboratory at the University Hospital of Jaén. “As Concentriq Dx is flexible and open, it will allow us to leverage the latest innovations in digital and computational pathology throughout the Andalusian region to best serve our patients.”

In addition to integrating with leading scanners, laboratory information systems, and image analysis applications, Concentriq Dx is AI-ready and designed to support laboratories in realizing pathology’s computational future. The platform will support the future integration of AI applications into clinical workflows, enabling pathologists to expand the breadth of diagnostic information available and view these insights alongside all of their other pathology data to better inform diagnosis.

“Digital pathology is delivering real benefits today and holds even more promise for tomorrow,” said Arun Ananth, Proscia’s Chief Commercial Officer. “As we formally expand into Spain, it is especially energizing to work with a laboratory that is eager to capitalize on the unfolding potential in seeing through its commitment to excellent patient care.”

Recommended AI News: Telefónica Tech Joins Forces with Netskope to Bring Cloud Security Solutions to the Corporate Environment

[To share your insights with us, please write to sghosh@martechseries.com]